Akira Shouzu Selected Research

Akira Shouzu Research Topics

Disease

13	Type 2 Diabetes Mellitus (MODY) 01/2018 - 04/2004
5	Thrombosis (Thrombus) 01/2015 - 01/2009
5	Atherosclerosis 01/2015 - 04/2004
4	Hypertension (High Blood Pressure) 09/2009 - 04/2004
3	Hyperlipidemias (Hyperlipidemia) 01/2012 - 01/2008
3	Hyperglycemia 01/2011 - 04/2004
2	Diabetes Mellitus 09/2009 - 04/2004
2	Diabetic Angiopathies (Diabetic Angiopathy) 09/2005 - 07/2004
1	Arteriosclerosis Obliterans 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Lacunar Stroke 01/2009
1	Heart Failure 01/2009
1	Atherosclerotic Plaque (Atheroma) 01/2009
1	Infarction (Infarctions) 01/2009
1	Cerebral Infarction 01/2009
1	Vascular System Injuries 01/2009
1	Acute Coronary Syndrome 01/2009
1	Diabetes Complications 01/2006
1	Hypoadiponectinemia 01/2006
1	Hypercholesterolemia 01/2005
1	Thrombophilia 12/2004

Drug/Important Bio-Agent (IBA)

9	AdiponectinIBA 01/2015 - 09/2005
8	RV 538 (PDMP)IBA 01/2012 - 07/2004
5	SelectinsIBA 01/2015 - 12/2004
4	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2008
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012 - 04/2004
4	ChemokinesIBA 09/2009 - 04/2004
4	P-SelectinIBA 09/2009 - 07/2004
3	Eicosapentaenoic AcidIBA 01/2018 - 02/2009
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2009 - 09/2005
3	Cell Adhesion MoleculesIBA 09/2009 - 12/2004
3	E-SelectinIBA 09/2009 - 09/2005
2	sarpogrelateIBA 01/2018 - 09/2005
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
2	CD40 Ligand (CD40L)IBA 09/2009 - 07/2004
2	2- (4- methyl- 2,6- dinitroanilino)- N- methylpropionamide (MDMP)IBA 09/2009 - 01/2005
2	Chemokine CCL5IBA 09/2009 - 01/2005
2	oxidized low density lipoproteinIBA 01/2008 - 07/2004
2	Annexin A5IBA 09/2005 - 01/2005
2	Simvastatin (Zocor)FDA LinkGeneric 12/2004 - 04/2004
2	Losartan (Cozaar)FDA LinkGeneric 12/2004 - 04/2004
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2016
1	Advanced Glycation End ProductsIBA 01/2015
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015
1	Plasminogen Activator Inhibitor 1IBA 01/2012
1	miglitol (Glyset)FDA Link 01/2011
1	CreatinineIBA 09/2009
1	lipoprotein cholesterolIBA 09/2009
1	Angiopoietin-2IBA 04/2009
1	AngiopoietinsIBA 04/2009
1	Hemostatics (Antihemorrhagics)IBA 01/2009
1	Thromboplastin (Tissue Factor)IBA 01/2009
1	CholesterolIBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2006
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2006
1	Lipopolysaccharide ReceptorsIBA 01/2006
1	Peptides (Polypeptides)IBA 01/2006
1	Valsartan (Vals)FDA Link 01/2006
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 09/2005
1	Serotonin AntagonistsIBA 09/2005
1	CalciumIBA 01/2005
1	Nifedipine (Adalat)FDA LinkGeneric 01/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2005
1	CC ChemokinesIBA 01/2005
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2005
1	LipidsIBA 12/2004
1	Angiotensin IIIBA 04/2004
1	Angiotensin Receptor AntagonistsIBA 04/2004
1	Ticlopidine (Ticlid)FDA LinkGeneric 04/2004

Therapy/Procedure

5	Therapeutics 01/2009 - 04/2004
1	Renal Dialysis (Hemodialysis) 01/2016